A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden

Author： Lindström Eva   Eberhard Jonas   Fors Björn M.   Hansen Karina   Sapin Christophe  

Publisher： Informa Healthcare

ISSN： 0803-9488

Source： Nordic Journal of Psychiatry, Vol.65, Iss.6, 2011-12, pp. : 403-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sertindole improves both the positive and negative symptoms of schizophrenia: Results of a phase III trial

By Hale Anthony   Azorin Jean-Michel   Kasper Siegfried   Maier Wolfgang   Syvalahti Erkka   Burght Michael Van Der   Sloth-Nielsen Mogens   Wehnert Allan  

International Journal of Psychiatry in Clinical Practice, Vol. 4, Iss. 1, 2000-03 ,pp. : 55-62

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A cost-effectiveness analysis of escitalopram as first line treatment of depression in Sweden

By Löthgren Mickael   Hemels Michiel   François Clément   Jönsson Bengt  

Primary Care Psychiatry, Vol. 9, Iss. 4, 2004-12 ,pp. : 153-162

Informa Healthcare

Access to resources Recommend Favorite

Mortality among persons with schizophrenia in Sweden: An epidemiological study

By Fors Björn Milesson   Isacson Dag   Bingefors Kerstin   Widerlöv Birgitta  

Nordic Journal of Psychiatry, Vol. 61, Iss. 4, 2007-01 ,pp. : 252-259

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological treatment of schizophrenia

By Gadelha Ary   Noto Cristiano Souza   de Jesus Mari Jair  

International Review of Psychiatry, Vol. 24, Iss. 5, 2012-10 ,pp. : 489-498

Informa Healthcare

Access to resources Recommend Favorite

Aripiprazole: a new treatment for schizophrenia

By Bourin Michel  

Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. : 373-388

Future Medicine

Access to resources Recommend Favorite